The SARS-CoV-2 main protease as drug target S Ullrich, C Nitsche Bioorganic & Medicinal Chemistry Letters 30 (17), 127377, 2020 | 689 | 2020 |
Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir S Ullrich, KB Ekanayake, G Otting, C Nitsche Bioorganic & Medicinal Chemistry Letters 62, 128629, 2022 | 176 | 2022 |
Antiviral cyclic peptides targeting the main protease of SARS-CoV-2 J Johansen-Leete, S Ullrich, SE Fry, R Frkic, MJ Bedding, A Aggarwal, ... Chemical Science 13, 3826-3836, 2022 | 41 | 2022 |
SARS-CoV-2 papain-like protease: Structure, function and inhibition S Ullrich, C Nitsche ChemBioChem 23 (19), e202200327, 2022 | 32 | 2022 |
Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors S Ullrich, VM Sasi, MC Mahawaththa, KB Ekanayake, R Morewood, ... Bioorganic & Medicinal Chemistry Letters 50, 128333, 2021 | 29 | 2021 |
Predicting antiviral resistance mutations in SARS-CoV-2 main protease with computational and experimental screening VM Sasi#, S Ullrich#, J Ton, SE Fry, J Johansen-Leete, RJ Payne, ... Biochemistry 61 (22), 2495-2505, 2022 | 26 | 2022 |
Biocompatible and selective generation of bicyclic peptides S Ullrich, J George, AE Coram, R Morewood, C Nitsche Angewandte Chemie International Edition 61 (43), e202208400, 2022 | 14 | 2022 |
Bicyclic peptides: Paving the road for therapeutics of the future S Ullrich, C Nitsche Peptide Science 116 (2), e24326, 2024 | 5 | 2024 |
Probing ligand binding sites on large proteins by nuclear magnetic resonance spectroscopy of genetically encoded non-canonical amino acids KB Ekanayake, MC Mahawaththa, H Qianzhu, EH Abdelkader, J George, ... Journal of Medicinal Chemistry 66 (7), 5289-5304, 2023 | 5 | 2023 |
Site-selective generation of lanthanoid binding sites on proteins using 4-fluoro-2,6-dicyanopyridine S Mekkattu Tharayil, MC Mahawaththa, A Feintuch, A Maleckis, S Ullrich, ... Magnetic Resonance 3 (2), 169-182, 2022 | 1 | 2022 |
Exploiting hydrophobic amino acid scanning to develop cyclic peptide inhibitors of the SARS-CoV-2 main protease with antiviral activity K Harrison, P Carlos, S Ullrich, A Aggarwal, J Johansen-Leete, ... Chemistry - A European Journal, https://doi.org/10.1002/chem.202401606, 2024 | | 2024 |
Phage-encoded bismuth bicycles: Instant access to targeted bioactive peptides S Ullrich#, U Somathilake#, M Shang, C Nitsche bioRxiv, http://doi.org/10.1101/2024.04.10.588800, 2024 | | 2024 |
Modified peptides as viral protease inhibitors S Ullrich Australian National University, https://doi.org/10.25911/J0S0-2E61, 2024 | | 2024 |
A RaPID response to SARS-CoV-2 S Ullrich, C Nitsche Israel Journal of Chemistry, https://doi.org/10.1002/ijch.202300170, 2024 | | 2024 |
4-Fluoro-2,6-dicyanopyridine S Ullrich, C Nitsche Encyclopedia of Reagents for Organic Synthesis, 2024 | | 2024 |